During the last three months, 12 analysts shared their evaluations of Corteva CTVA, revealing diverse outlooks from bullish to bearish.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 5 | 6 | 1 | 0 | 0 |
| Last 30D | 0 | 1 | 0 | 0 | 0 |
| 1M Ago | 2 | 2 | 0 | 0 | 0 |
| 2M Ago | 2 | 2 | 1 | 0 | 0 |
| 3M Ago | 1 | 1 | 0 | 0 | 0 |
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $68.17, a high estimate of $73.00, and a low estimate of $62.00. This current average reflects an increase of 3.71% from the previous average price target of $65.73.
Diving into Analyst Ratings: An In-Depth Exploration
The standing of Corteva among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Arun Viswanathan | RBC Capital | Raises | Outperform | $73.00 | $68.00 |
| Patrick Cunningham | Citigroup | Lowers | Buy | $69.00 | $70.00 |
| Aleksey Yefremov | Keybanc | Raises | Overweight | $69.00 | $66.00 |
| Richard Garchitorena | Wells Fargo | Raises | Overweight | $67.00 | $65.00 |
| Steve Byrne | B of A Securities | Raises | Buy | $69.00 | $67.00 |
| Arun Viswanathan | RBC Capital | Lowers | Outperform | $68.00 | $69.00 |
| Benjamin Theurer | Barclays | Raises | Equal-Weight | $62.00 | $58.00 |
| Kristen Owen | Oppenheimer | Raises | Outperform | $70.00 | $69.00 |
| Joshua Spector | UBS | Raises | Buy | $71.00 | $67.00 |
| Patrick Cunningham | Citigroup | Announces | Buy | $68.00 | - |
| Steve Byrne | B of A Securities | Raises | Buy | $67.00 | $59.00 |
| Vincent Andrews | Morgan Stanley | Maintains | Overweight | $65.00 | $65.00 |
Key Insights:
- Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Corteva. This information offers a snapshot of how analysts perceive the current state of the company.
- Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Corteva compared to the broader market.
- Price Targets: Analysts navigate through adjustments in price targets, providing estimates for Corteva's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Corteva's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
Stay up to date on Corteva analyst ratings.
Unveiling the Story Behind Corteva
Corteva is an agricultural inputs pure play that was formed in 2019 when it was spun off from DowDuPont. The company is a leader in the development of new seed and crop protection products. Seeds generate the majority of profits with the remainder coming from crop protection products. Corteva operates globally, but around half of revenue comes from North America.
Financial Milestones: Corteva's Journey
Market Capitalization Analysis: Above industry benchmarks, the company's market capitalization emphasizes a noteworthy size, indicative of a strong market presence.
Decline in Revenue: Over the 3 months period, Corteva faced challenges, resulting in a decline of approximately -10.19% in revenue growth as of 30 September, 2024. This signifies a reduction in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Materials sector.
Net Margin: Corteva's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of -22.53%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Corteva's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of -2.1%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): Corteva's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of -1.26%, the company may face hurdles in achieving optimal financial returns.
Debt Management: Corteva's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.23.
Understanding the Relevance of Analyst Ratings
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. Click here for urgent details.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
